ArticleScientific reports2026
Novel green synthesis of polyfunctionally substituted phthalazines promoted by visible light, DFT studies and molecular docking with antimicrobial and antibiofilm potency.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phthalazine as a medically versatile polyheterocyclic core with underexplored anticancer potential.Journal of enzyme inhibition and medicinal chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visible-Light-Mediated synthesis is a green and efficient technique that has garnered interest from organic chemists. A new series of polyfunctionally substituted phthalazine derivatives 3a-j were synthesized via a metal-free reaction of pyridazines 1a-d with arylidenes 2a-d in the presence of a catalytic amount of piperidine, in absolute ethanol as a solvent, under white LED lamp irradiation at room temperature using open air as oxidant, in 90-93% yields. A radical mechanism via single-electron transfer (SET) was confirmed using a radical scavenger. All synthesized products 3a-j were screened as potential antimicrobial and antibiofilm agents. Both compounds 3g and 3j are the most promising derivatives. Compound 3g displayed outstanding activity against Pseudomonas aeruginosa and Klebsiella pneumoniae with a MIC value of 3.12 and 12.5 µg/mL, respectively. Compound 3j gave a Minimum Inhibitory Concentration (MIC) value of 6.25 µg/mL for P. aeruginosa. As prospective antibiofilm agents against P. aeruginosa, compounds 3g and 3j exhibited inhibition with 81% and 75%, respectively. The geometrical structures were optimized using Density Functional Theory (DFT), frontier molecular orbitals (HOMO-LUMO), along with global reactivity descriptors, such as chemical potential, electronegativity and electrophilicity, were computed to assess the compounds' chemical reactivity and stability. Spectral characteristics were interpreted to support the theoretical findings, while Molecular Electrostatic Potential (MEP) mapping was employed to visualize charge distribution and potential reactive sites. Furthermore, topological analyses, including Electron Localization Function (ELF) and Reduced Density Gradient/Non-Covalent Interaction (RDG/NCI) analysis, offered insights into intra- and intermolecular interactions and the nature of non-covalent bonding. Molecular docking simulations were performed and revealed favorable binding affinities and key interactions within the active sites, indicating potential antimicrobial and enzyme-inhibitory properties, especially with 3j-3LD6 with binding energy of - 9.5 kcal/mol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.